Platelet Rich Plasma Market Size & Share Report, 2032

Platelet Rich Plasma (PRP) Market – By Type [Pure Platelet-Rich Plasma (P-PRP), Leukocyte- and Platelet Rich Plasmas (L-PRP)] Origin (Autologous, Allogenic), Application (Orthopedics & Sports Medicine, Cosmetic Surgery), End-use, Forecast 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp;Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp;Research design

1.2.1&nbsp;&nbsp;&nbsp;Research approach

1.2.2&nbsp;&nbsp;&nbsp;Data collection methods

1.3&nbsp;&nbsp;&nbsp;Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp;Base year calculation

1.3.2&nbsp;&nbsp;&nbsp;Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp;Forecast model

1.5&nbsp;&nbsp;&nbsp;Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp;Primary sources

1.5.2&nbsp;&nbsp;&nbsp;Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary 

2.1&nbsp;&nbsp;&nbsp;Industry 360&deg; synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights 

3.1&nbsp;&nbsp;&nbsp;Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp;Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp;Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing prevalence of sports injuries and orthopedic conditions

3.2.1.2&nbsp;&nbsp;&nbsp;Growing cosmetic and aesthetic applications

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing awareness and acceptance of regenerative medicine

3.2.2&nbsp;&nbsp;&nbsp;Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High cost

3.2.2.2&nbsp;&nbsp;&nbsp;Lack of standardization

3.3&nbsp;&nbsp;&nbsp;Growth potential analysis

3.4&nbsp;&nbsp;&nbsp;Regulatory landscape

3.5&nbsp;&nbsp;&nbsp;Technology landscape

3.6&nbsp;&nbsp;&nbsp;Future market trends

3.7&nbsp;&nbsp;&nbsp;Porter&rsquo;s analysis

3.8&nbsp;&nbsp;&nbsp;PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp;Introduction

4.2&nbsp;&nbsp;&nbsp;Company matrix analysis

4.3&nbsp;&nbsp;&nbsp;Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp;Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp;Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp;Key trends

5.2&nbsp;&nbsp;&nbsp;Pure platelet-rich plasma (P-PRP)

5.3&nbsp;&nbsp;&nbsp;Leukocyte- and platelet rich plasma (L-PRP)

5.4&nbsp;&nbsp;&nbsp;Other types

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Origin, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp;Key trends

6.2&nbsp;&nbsp;&nbsp;Autologous

6.3&nbsp;&nbsp;&nbsp;Allogenic

6.4&nbsp;&nbsp;&nbsp;Homologous

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp;Key trends

7.2&nbsp;&nbsp;&nbsp;Orthopedics &amp; sports medicine

7.3&nbsp;&nbsp;&nbsp;Cosmetic surgery and dermatology

7.4&nbsp;&nbsp;&nbsp;Neurology

7.5&nbsp;&nbsp;&nbsp;Cardiology

7.6&nbsp;&nbsp;&nbsp;Ophthalmology

7.7&nbsp;&nbsp;&nbsp;Other applications

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-use, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp;Key trends

8.2&nbsp;&nbsp;&nbsp;Hospitals

8.3&nbsp;&nbsp;&nbsp;Specialty clinics

8.4&nbsp;&nbsp;&nbsp;Ambulatory surgical centers

8.5&nbsp;&nbsp;&nbsp;Other end-users

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp;Key trends

9.2&nbsp;&nbsp;&nbsp;North America

9.2.1&nbsp;&nbsp;&nbsp;U.S.

9.2.2&nbsp;&nbsp;&nbsp;Canada

9.3&nbsp;&nbsp;&nbsp;Europe

9.3.1&nbsp;&nbsp;&nbsp;Germany

9.3.2&nbsp;&nbsp;&nbsp;UK

9.3.3&nbsp;&nbsp;&nbsp;France

9.3.4&nbsp;&nbsp;&nbsp;Spain

9.3.5&nbsp;&nbsp;&nbsp;Italy

9.3.6&nbsp;&nbsp;&nbsp;Poland

9.3.7&nbsp;&nbsp;&nbsp;Netherlands

9.3.8&nbsp;&nbsp;&nbsp;Rest of Europe

9.4&nbsp;&nbsp;&nbsp;Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp;China

9.4.2&nbsp;&nbsp;&nbsp;Japan

9.4.3&nbsp;&nbsp;&nbsp;India

9.4.4&nbsp;&nbsp;&nbsp;Australia

9.4.5&nbsp;&nbsp;&nbsp;South Korea

9.4.6&nbsp;&nbsp;&nbsp;Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp;Latin America

9.5.1&nbsp;&nbsp;&nbsp;Brazil

9.5.2&nbsp;&nbsp;&nbsp;Mexico

9.5.3&nbsp;&nbsp;&nbsp;Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp;South Africa

9.6.2&nbsp;&nbsp;&nbsp;Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp;UAE

9.6.4&nbsp;&nbsp;&nbsp;Rest of Middle East and Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles 

10.1&nbsp;&nbsp;&nbsp; Arthrex Inc.

10.2&nbsp;&nbsp;&nbsp; APEX Biologix

10.3&nbsp;&nbsp;&nbsp; Celling Biosciences, Inc.

10.4&nbsp;&nbsp;&nbsp; DePuy Synthes (Johnson &amp; Johnson)

10.5&nbsp;&nbsp;&nbsp; Dr. PRP USA LLC

10.6&nbsp;&nbsp;&nbsp; EmCyte Corporation

10.7&nbsp;&nbsp;&nbsp; Exactech, Inc.

10.8&nbsp;&nbsp;&nbsp; Glofinn Oy

10.9&nbsp;&nbsp;&nbsp; Isto Biologics

10.10&nbsp;&nbsp;&nbsp; Juventix Regenerative Medical, LLC.

10.11&nbsp;&nbsp;&nbsp; Regen Lab SA

10.12&nbsp;&nbsp;&nbsp; Terumo BCT, Inc.

10.13&nbsp;&nbsp;&nbsp; ThermoGenesis Holdings Inc.

10.14&nbsp;&nbsp;&nbsp; Vivostat A/S

&nbsp;&nbsp;&nbsp;

Platelet Rich Plasma PRP Market

Get a free sample of this report